REFERENCES

1. Du K., Mei Y. J., Cao X. T., Zhang P. F., and Zheng, H. “The Synthesis of Pyrazole Derivatives Based on Glucose,” International Journal of Recent Trends in Science And Technology, 2013, 4, 238-240.
2. Tewari A. K. and Mishra, A. “Synthesis and anti-inflammatory activities of N4, N5-disubstituted-3-methyl-1H-pyrazolo [3, 4-c] pyrida-zines,” Bioorg. Med. Chem., 2001, 9, 715-718.
3. Park H. J., Lee K., Park S. J., Ahn B., Lee J. C., Cho H. Y., and Lee K. I.“Identification of antitumor activity of pyrazole oxime ethers,” Bioorg. Med. Chem. Lett., 2005,15, 3307-3312.
4. Bouabdallah I,. Barret L. A., Zyad A., Ramadan A., Zidane I., and Melhaoui A. “Anticancer effect of three pyrazole derivatives,” Nat. Prod. Res., 2006, 20, 1024-1030.
5. Pimerova E. V. and Voronina, E. V. “Antimicrobial activity of pyrazoles and pyridazines obtained by interaction of 4-aryl-3-arylhydrazono-2, 4-dioxobutanoic acids and their esters with hydrazines,” Pharm. Chem. J., 2001, 35, 602-604.
6. Janus S. L., Magdif A. Z., Erik B. P., and Claus N., “Synthesis of triazenopyrazole derivatives as potential inhibitors of HIV-1,” Monatsh. Chem., 1999, 130, 1167-1174.
7. Michon V., Penhoat C. H. Du, Tombret F., Gillardin J. M., Lepagez, F. and Berthon L., “Preparation, structural analysis and anticonvulsant activity of 3- and 5-aminopyrazole N-benzoyl derivatives,” Eur. J. Med.Chem., 1995, 30, 147-155.
8. Chu C. K. and Cutler J. J., “Chemistry and antiviral activities of acyclonucleosides,” Heterocyclic. Chem. , 1986, 23, 289-319.
9. Genin M. J., Biles C., Keiser B. J., Poppe S. M., Swaney S. M., Tarpley W. G., Yagi, Y. and Romero D. L., “Novel 1,5-Diphenylpyrazole Non-nucleoside HIV-1 Reverse Transcriptase Inhibitors with Enhanced Activity versus the Delavirdine-Resistant P236L Mutant: Lead Identification and SAR of 3- and 4-Substituted Derivatives,” J.  Med. Chem., 2000, 43, 1034-1040.
10. Y. R. Huang and J. A. Katzenellenbogen, “Regioselective synthesis of 1,3,5-triaryl-4-alkylpyrazoles: novel ligands for the estrogen receptor,” Org. Lett., 2000, 2, 2833-2836.
11. Stauffer S. R., Coletta C. J., Tedesco R., Nishiguchi G., Carlson K., Sun J., Katzenellenbogen B. S., and Katzenellenbogen J. A., “Pyrazole Ligands: Structure-Affinity/Activity Relationships and Estrogen Receptor-α-Selective Agonists,” J. Med. Chem., 2000, 43, 4934-4947.
12. Okafor E. C., “The metal complexes of heterocyclic β-diketones and their derivatives—V. The synthesis, structure and i.r. spectral studies of metal(II) complexes of 1-phenyl-3-methyl-4-acetyl-pyrazolone-5 (HPMAP)” SpectrochemicaActa, 1981, 37A, 939-945 .
13. Okafor E. C, “The metal complexes of heterocyclic β-diketones and their derivatives—VI. The synthesis, structure and i.r. spectral studies of some new metal(II) complexes of 1-phenyl-3-methyl-4-benzoyl-pyrazolone-5 (HPMBP)” SpectrochemicaActa, 1981, 37A, 945-952.
14. Perrin D.D., Armarego W.L.F., Perrin D.R., Purification of Laboratory Chemicals, 2nd ed.; Pergoman Press: New York, 1980.
15.  Mehrotra R.C., Singh A., Recent Trends in Metal Alkoxide Chemistry. Prog. Inorg. Chem. 1997, 46, 239.
16. Jensen B. S, Synthesis of 1-​phenyl-​3-​methyl-​4-​acyl-​5-​pyrazolones . Acta. Chem. Scand, 1959, 13 1668-1670.
17. Vogel, A.I. A Text Book of Quantitative Chemical Analyses, 5th Edn; Longman: London, 1989.
18. Bradley, D. C.; Halim, F. M. Abd-El; Wardlaw, W. “The chloride ethoxides of zirconium” J. Chem. Soc., 1950, 3450-4.